Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating Efficacy and Safety of Crisaborole in Adults With Stasis Dermatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participants who are ≥45 years of age and in generally stable health~* Participants who are in generally stable health and have a known diagnosis of Stasis Dermatitis or newly diagnosed Stasis Dermatitis~* Participants whose mental and physical status allows them to be able to mostly perform their activities of daily living with minimal assistance~Exclusion Criteria:~* Participants with clinically significant active or potentially recurrent dermatitis conditions and known genetic dermatological conditions that are not Stasis Dermatitis or overlap with Stasis Dermatitis~* Participants with active venous stasis ulceration on either lower extremity.~* Participants with current infection or suspected infection of any Stasis Dermatitis lesions~* Women of child bearing potential (WOCBP) are not eligible for this study

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- crisaborole ointment (Type: EXPERIMENTAL): crisaborole ointment
- vehicle ointment (Type: SHAM_COMPARATOR): vehicle ointment

Based on this trial design, predict the completion outcome and termination type (if applicable).